Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.
Ouk K, Aungier J, Cuesta M, Morton AJ. Ouk K, et al. Neuropharmacology. 2018 Mar 15;131:337-350. doi: 10.1016/j.neuropharm.2017.12.033. Epub 2017 Dec 21. Neuropharmacology. 2018. PMID: 29274752
Striatal transplantation in a transgenic mouse model of Huntington's disease.
Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ. Dunnett SB, et al. Exp Neurol. 1998 Nov;154(1):31-40. doi: 10.1006/exnr.1998.6926. Exp Neurol. 1998. PMID: 9875265
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Carter RJ, et al. J Neurosci. 1999 Apr 15;19(8):3248-57. doi: 10.1523/JNEUROSCI.19-08-03248.1999. J Neurosci. 1999. PMID: 10191337 Free PMC article.
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Murphy KP, et al. J Neurosci. 2000 Jul 1;20(13):5115-23. doi: 10.1523/JNEUROSCI.20-13-05115.2000. J Neurosci. 2000. PMID: 10864968 Free PMC article.
194 results
Jump to page
Feedback